| 2/6/2024 | BKHY | Moody’s eyes Catalent for upgrade
|
| 2/5/2024 | BKCVDDEMIGPV | Market Commentary: Post Holdings, NOVA drive-by; Stena, Ardonagh on deck; Allied struggles; Catalent surges on takeover
|
| 12/14/2023 | BK | Market Commentary: USI, Nuvei, Travel + Leisure, Summit, Catalent break; Davis, ArcLight, TouchTunes updated
|
| 12/14/2023 | BK | Catalent ups term loan to $600 million, firms at SOFR plus 300 bps
|
| 12/13/2023 | BK | Market Commentary: Innio, Citadel, R1 RCM, A-Gas break; USI revised; Summit Behavioral, Catalent accelerated
|
| 12/11/2023 | BK | Market Commentary: IntraFi sets final terms; Chobani accelerated; Castlelake, Playa and more disclose talk
|
| 12/11/2023 | BKHY | Moody’s rates Catalent Pharma loan Ba2
|
| 12/11/2023 | BK | Catalent launches $500 million term loan B-4 at SOFR plus 300-325 bps
|
| 12/11/2023 | BKHY | S&P cuts loan, rates Catalent loan BB-
|
| 11/28/2023 | BK | Catalent amends to extend deadlines for delivery of financials
|
| 8/29/2023 | BKCVDDEMIGPV | Market Commentary: JOLTS report jolts buyers in junk secondary; Catalent rises; Ford improves; Coinbase gains
|
| 6/26/2023 | BKHY | Moody’s turns Catalent view to stable
|
| 6/8/2023 | BKHY | Moody's downgrades Catalent
|
| 5/8/2023 | BKCVDDEMIGPV | Market Commentary: Ball, Northern Oil and Gas drive-by; Heartland Dental flat; Catalent tumbles
|
| 4/17/2023 | BKHY | Moody's eyes Catalent for downgrade
|
| 4/14/2023 | BKCVDDEMIGPV | Market Commentary: Junk: Baytex at a premium; Spirit Aero ails on supply gaffe; Catalent down on profit warning
|
| 11/2/2021 | BKBWHY | Catalent aims to de-lever naturally after raising $1.1 billion debt
|
| 9/23/2021 | BKHY | Moody's gives B1 to Catalent notes
|
| 9/23/2021 | BKHY | S&P assigns Catalent notes BB-
|
| 8/31/2021 | BKBWHY | Catalent CEO, CFO discuss plans for Bettera acquisition
|
| 2/10/2021 | BK | Market Commentary: Ensemble Health, Ontic, Catalent break; Precision, Compassus, Cotiviti deal changes surface
|
| 2/10/2021 | BKHY | Moody’s assigns B1 to Catalent’s notes
|
| 2/10/2021 | BK | Catalent lifts term loan to $1 billion, firms at Libor plus 200 bps
|
| 2/10/2021 | BKHY | S&P gives Catalent notes BB-
|
| 2/3/2021 | BK | Market Commentary: Foundation, Pretium, Navitas, Rackspace, Parexel break; ION, Idera, Kloeckner updated
|
| 2/3/2021 | BK | Catalent launches $933 million term loan at Libor plus 200-225 bps
|
| 11/18/2020 | BKHY | Moody’s upgrades Catalent
|
| 4/23/2020 | BKHY | S&P ups Catalent senior secured rating
|
| 2/28/2020 | BKHY | Moody’s ups Catalent loans
|
| 2/20/2020 | BK | Moody's cuts Auris Luxembourg II
|
| 2/20/2020 | BKHY | Moody’s assigns Catalent notes B3
|
| 2/19/2020 | BKHY | S&P rates Catalent Pharma notes B+
|
| 6/24/2019 | BKCVDDEMIGPV | Market Commentary: Primary market prices $4.01 billion in deals from Herc, Post, NextEra, Catalent, more
|
| 6/24/2019 | BKHY | Moody’s rates Catalent notes B3
|
| 6/24/2019 | BKHY | S&P rates Catalent Pharma notes B+
|
| 6/24/2019 | BK | Catalent to repay term loan borrowings with proceeds from new notes
|
| 5/20/2019 | BK | Catalent ups revolver by $350 million to help fund Paragon purchase
|
| 5/9/2019 | BK | Market Commentary: Catalent Pharma, LightBox, ThoughtWorks break; Oryx Midstream, FirstLight revise deals
|
| 5/9/2019 | BK | Catalent firms $950 million term loan B at discount of 99.75
|
| 5/9/2019 | BKHY | Moody's lowers Catalent, rates loan Ba3
|
| 5/8/2019 | BK | Catalent lifts term B to $950 million, flexes to Libor plus 225 bps
|
| 4/29/2019 | BK | Market Commentary: Kestra, NVA, Livingston, Sound Physicians free to trade; Flexera moves commitment deadline
|
| 4/29/2019 | BK | Catalent Pharma to launch $650 million term loan B on Tuesday
|
| 8/6/2018 | BKHY | Moody’s ups Catalent facility
|
| 10/16/2017 | BKCVDDEMIGPV | Market Commentary: Pattonair prices; new Friday names busy; Ruby Tuesday jumps on buyout; hospitals steady
|
| 10/13/2017 | BKCVDDEMIGPV | Market Commentary: UPC, Catalent, Vine price deals; new attack on ACA roils hospitals
|
| 10/11/2017 | BK | Market Commentary: Dell Technologies launches $4.79 billion repricing; Beacon, Catalent, Fuller narrow terms
|
| 10/11/2017 | BK | Catalent firms U.S. loan at tight of end talk, euro loan tighter
|
| 10/10/2017 | BKHY | Moody’s rates Catalent Pharma notes B3
|
| 10/10/2017 | BKHY | S&P cuts Catalent debt, rates notes B+
|
| 10/4/2017 | BK | Moody’s: Catalent Pharma facilities Ba3
|
| 10/4/2017 | BK | Market Commentary: Camping World, Lighthouse Network break; Sterling Talent, VerticalScope update deal terms
|
| 10/4/2017 | BK | Catalent Pharma discloses price talk on U.S. and euro term loans
|
| 10/3/2017 | BK | Market Commentary: West breaks; Camping World, NCL, CPA Global updated; Duff & Phelps modifies deadline
|
| 10/3/2017 | BK | Catalent to launch U.S. and euro term B repricing, extension Wednesday
|
| 12/2/2016 | BK | Market Commentary: Albertsons, USIC, Save-A-Lot, Zebra, AdvancePierre break; Catalent, Quikrete changes emerge
|
| 12/2/2016 | BK | Catalent updates spreads on U.S. and euro term loan B repricing
|
| 11/28/2016 | BK | Market Commentary: RevSpring breaks atop OID; CHG adjusts issue price; Zebra, Catalent launch repricings
|
| 11/28/2016 | BKHY | Moody’s ups Catalent loans, rates notes B3
|
| 11/28/2016 | BK | Catalent launches U.S. and euro term loan B repricing to lenders
|
| 11/28/2016 | BKHY | S&P assigns BB- to Catalent notes
|
| 9/13/2016 | BK | Catalent plans to draw on revolver to fund acquisition of Pharmatek
|
| 4/18/2016 | BK | S&P affirms Catalent Pharma
|
| 2/11/2016 | BK | Market Commentary: Bids on three BWICs come due; Alpha Media takes second crack at first-lien loan syndication
|
| 10/26/2015 | BK | Moody’s changes Catalent view to stable
|
| 11/24/2014 | BK | Market Commentary: Catalent breaks; Hudson’s Bay weakens; Tibco, C&J, Packers, Global Cash, Equinox revised
|
| 11/21/2014 | BK | Market Commentary: CareCore frees to trade; Catalent Pharma tweaks size, issue prices; Q Holdings reveals talk
|
| 11/21/2014 | BK | Catalent Pharma lifts add-on term loan B to $190 million equivalent
|
| 11/20/2014 | BK | Market Commentary: Creganna-Tactx, Navex break; B/E Aerospace, Parq, Tecomet, Camping World, Abaco update deals
|
| 11/20/2014 | BK | Catalent Pharma launches $180 million equivalent add-on term loan B
|
| 10/20/2014 | BKDD | Moody’s lifts Catalent CFR, loan; cuts loans
|
| 8/8/2014 | BK | S&P upgrades Catalent
|
| 7/31/2014 | BKDD | Moody’s reviews Catalent Pharma
|
| 7/24/2014 | BKDDHY | S&P: Catalent Pharma on positive watch
|
| 5/8/2014 | BK | Catalent Pharma shifts funds between U.S. and euro term loans
|
| 5/8/2014 | BK | Market Commentary: Catalent, TravelClick, Jonah break; Ortho-Clinical, Environmental, Schaeffler, Joerns tweaked
|
| 4/30/2014 | BK | Catalent Pharma sets U.S. and euro term loan B talk with launch
|
| 4/30/2014 | BK | Market Commentary: Momentive breaks; TASC tweaks deal; Catalent, NAB, SI Organization, Albaugh set talk
|
| 4/30/2014 | BKDDHY | S&P rates Catalent loan BB-
|
| 4/30/2014 | BKHY | Moody's assigns Catalent loans Ba3
|
| 4/29/2014 | BK | Market Commentary: Boyd, Select Staffing, Totes Isotoner, USI Insurance break; Momentive reworks term loan
|
| 4/29/2014 | BK | Catalent Pharma to launch roughly $1.9 billion facility on Wednesday
|
| 4/29/2013 | BKDD | Moody's: Catalent Pharma loan Caa1
|
| 4/25/2013 | BKHY | S&P rates Catalent loan B
|
| 4/24/2013 | BK | Catalent Pharma launches $275 million unsecured term loan to investors
|
| 4/24/2013 | BK | Market Commentary: 24 Hour, Covis break; SourceHOV, Harland Clarke, CDW, Caraustar, Harden, Truven tweak deals
|
| 3/8/2013 | BKHY | Moody's: Catalent view negative
|
| 2/11/2013 | BK | Market Commentary: Tervita, FairPoint, PQ, CommScope, Catalent break; EnergySolutions gains with amendment
|
| 2/4/2013 | BK | Catalent seeks $60 million add-on, repricing of existing term debt
|
| 1/31/2013 | BK | Catalent Pharma Solutions schedules loan lender call for Friday
|
| 9/5/2012 | BKDDHY | Moody's: Catalent notes Caa1
|
| 5/3/2012 | BK | Catelent Pharma obtains $205 million refinancing dollar term 2 loan
|
| 4/25/2012 | BKDDHY | S&P rates Catalent loan BB-
|
| 4/24/2012 | BK | Catalent Pharma firms discount on $205 million add-on term loan at 991/2
|
| 4/24/2012 | BK | Market Commentary: Catalent, North American Bancard break; Travelport rises; Sabre up with extension proposal
|
| 4/23/2012 | BK | Catalent Pharma launches $205 million add-on term loan due 2017
|
| 4/23/2012 | BK | Market Commentary: First American Payment frees up; Hoffmaster, Catalent Pharma talk surfaces with launch
|
| 3/7/2012 | BKDDHY | Moody's: Catalent loan Ba3
|
| 2/22/2012 | BK | Catalent firms spread on $400 million term B at Libor plus 400 bps
|
| 2/22/2012 | BK | Market Commentary: Catalent Pharma, Focus Brands, Quintiles free up; EMI, Nuveen, Citadel Plastics rework deals
|
| 2/16/2012 | BKDDHY | S&P: Catalent unchanged
|
| 2/14/2012 | BK | Catalent launches $400 million add-on term B at Libor plus 375-400 bps
|
| 2/14/2012 | BK | Market Commentary: Schaeffler, TransDigm break; Telx ups deadline; Caribbean, New Asurion revise deals
|
| 2/13/2012 | BK | Catalent Pharma to launch $400 million add-on term B on Tuesday
|
| 2/13/2012 | BK | Market Commentary: Grifols breaks; Claire's, Sabre rise; Asurion shutting early; Schaeffler, ACCO tweak deals
|
| 11/16/2011 | BKDDHY | Moody's confirms Catalent, view up to stable
|
| 8/25/2011 | BKHY | S&P: Catalent unchanged
|
| 8/24/2011 | BK | Catalent Pharma plans term loan, revolver draw for acquisition
|
| 8/23/2011 | BKDDHY | Moody's may cut Catalent
|
| 6/7/2011 | BK | Catalent Pharma breaks $350 million revolver into two tranches
|
| 12/17/2010 | BKDDHY | Moody's ups Catalent to SGL-2
|
